Bekasi Asri Pemula Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Bekasi Asri Pemula Tbk trades at Rp240 (market cap 186.62B, 71.44M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 12.18M 24h volume). The key difference: Bekasi Asri Pemula Tbk is the larger of the two by market cap, and Bekasi Asri Pemula Tbk is more actively traded (71.44M versus 12.18M). Which is the better fit depends on your goals.
| BAPA | DKHH | |
|---|---|---|
Market Cap | 186.62B | 160.67B |
Volume | 71.44M | 12.18M |
Lot | 714.38K | 121.83K |
Turnover | 18.3B | 762.52M |
Average Price | 256.12 | 62.59 |
Value | 18.3B | 762.52M |
Indicative Equilibrium Price | 240 | 63 |
Indicative Equilibrium Volume | 16.81K | 2.19K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.
Read more on BAPA →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →